Essential thrombocythemia in a child. Diagnostic and therapeutic dilemma

Authors

• Ramyar Asghar, Department of Pediatrics, Children Medical Center Hospital, Tehran, Iran.
• Elahi Behzad, 2nd floor, No. 25, Maleki St, Gisha, Tehran, Iran. Tel. +98 (21) 8276071. E-mail: behzad448{at}yahoo.com
• Golsorkhtabar-Amiri Mohammad, Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

We report an 11-year-old child with essential thrombocythemia ET, a very rare myeloproliferative disorder among children. Essential thrombocythemia can be complicated by life-threatening thrombosis with a risk of converting into acute leukemia. Cytoreductive therapy may reduce the risk of thromboembolic complications. We usually recommend cytoreductive treatment for asymptomatic adult patients with platelet counts of more than 1.5 million/micro liter, but treatment remains obscure in children. Herein, we report the results of child with ET, treated successfully with hydroxuea.

Article Type

Case Report

First Page

1806

Last Page

1808

Recommended Citation

Asghar, Ramyar; Behzad, Elahi; and Mohammad, Golsorkhtabar-Amiri (2005) "Essential thrombocythemia in a child. Diagnostic and therapeutic dilemma," Saudi Medical Journal: Vol. 26: Iss. 11, Article 24.
DOI: https://doi.org/10.15537/1658-3175.3205